The FDA has approved the First Hormone Blockading Drug for Advanced Prostate Cancer

FDA just approved th first gonsdotropin-releasing hormone (GnRH) drug for the treatment of Advanced Prostate Cancer. This newly approved gonadotropin-releasing hormone (GnRH) receptor antagonist demonstrates rapid, long-term suppression of testosterone. Ferring Pharmaceuticals, USA (FP) received approval from the U.S. Food and Drug Administration (FDA) for degarelix, (generic name) which is a new injectable gonadotropin-releasing hormone [...]

FDA Approves New Drug to Alleviate Moderate to Severe Pain

The U.S. Food and Drug Administration (FDA) has approved a new drug which provides relief of moderate to severe acute pain. This is great news for us, because, advanced prostate cancer often brings pain from mets and breaking bones. This newly approved drug, tapentadol hydrochloride, is delivered as an immediate-release oral tablet. It is a [...]

The Sorry State Of Affairs With Advanced Prostate Cancer Research

I extracted the following from a news release published today about a new potential vaccine therapy for advanced prostate cancer. My reason for republishing it is not for the informational value, but is to share my feelings about the sorry state of prostate cancer treatment. Please read the press release and then my comments that [...]

Identifying That Tumor, Is It A Metastasis or A New Cancer?

Coincidentally, when I experienced my PSA recurrence of prostate cancer my rheumatologist suggested that I have an MRI to check up on the status of spinal involvement from my arthritis. After going through the usual struggles with the insurance company, I did have the MRI. While still dealing with the emotional issues of learning about [...]

The Role of FDA Advisory Committees

As new treatments, drugs and medical devices come to market the FDA is charged with making sure that they are both safe and perform as represented. Products that come under review include items such as human and animal drugs, blood and other biological products, medical devices, and foods. The process of evaluating these products has [...]

By |2017-10-19T10:57:14-04:00August 5th, 2008|Advanced Prostate Cancer, Advocacy, FDA, Uncategorized|0 Comments

Surrogate Endpoints – What They Are & Why They Are Important

On the Prostate Problems Mailing List there has been some recent discussion and a large amount of confusion expressed about the need for and importance of surrogate end points for drug and treatment approval. I attempted to make a very simple clarification and recommendation about surrogates. Here it is, but slightly modified ……. Maybe I [...]

A More Accurate Method To Monitor Metastatic Disease

According to the American Cancer Society, prostate cancer claims approximately 27,000 of us each year, the vast majority of our deaths are a result of recurrent metastatic disease. Metastatic prostate cancer occurs when tumor cells spread to other locations in the body and start to grow. Currently, when you start Chemotherapy the only way to [...]

FDA Approves Avastin – What A Surprise

To many people’s surprise on Friday the FDA approved Avastan in combination with the chemotherapy drug Paclitaxel for the treatment of breast cancer. Why was this a surprise? The FDA’s advisory committee voted 5 to 4 against approving the drug. In the clinical trial Avastan did not demonstrate a statistically improved survival rate. However, it [...]

Go to Top